3D remodelled DNA helix structure
About us We want to help people do more, feel better, live longer.
Today there are still millions of people without access to basic healthcare, thousands of diseases without adequate treatments and millions more people who suffer from everyday ailments. At GSK we want to change this.
Read morePress releases
- GSK announces US regulatory submission for mepolizumab in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
- GSK starts phase III study with mepolizumab in patients with nasal polyps
- GSK receives CHMP positive opinion for Synflorix pneumococcal vaccine four-dose vial
Tweets from GSK
-
GSK @GSK
Take a look at how @SinergiasAE created a healthcare delivery model for mums & children in remote areas of Colombia… twitter.com/i/web/status/8…
about 11 hours ago -
GSK @GSK
At GSK, there’s more to graduate life than work. Meet Peter. He’s spending a year in Japan 🇯🇵 and is embracing locatwitter.com/i/web/status/8…qd
about 14 hours ago -
GSK @GSK
Thanks to the students globally who voted for us as one of the world’s most attractive employers! Read more:… twitter.com/i/web/status/8…
about 14 hours ago
